Home » Newsletters » BioWorld Science

BioWorld Science

March 23, 2005

View Archived Issues

European Society of Cardiology guidelines recommend bivalirudin

Insmed and UCSF sign option agreement for IGF-1 receptor antagonists

Enzon terminates Marqibo agreement

Boehringer Ingelheim and MorphoSys expand cooperative efforts

Viragen anti-CD55 antibody enhances effect of Rituxan

sanofi pasteur seeks to broaden age group for Menactra vaccine

Cytogen updates Quadramet development efforts

Innovive licenses opioid growth factor from Penn State

Progression-free survival findings from ongoing CONFIRM 1 study

Combunox launched

ISTA submits IND for phase IIb study of ecabet sodium for dry eye syndrome

Dynavax Technologies and UCB end seasonal allergies collaboration

PhotoMedex and ProCyte shareholders approve merger

Teva issues reassurance on safety of Copaxone

Enrollment complete in pivotal study of panitumumab for colorectal cancer

Eupatilin reduces histamine release and leukotriene synthesis in OVA-sensitized mast cells

Therapeutic potential of CRIC-3 confirmed in murine models of allergic asthma

PD-0305970 displays excellent in vivo activity against Gram-positive bacterial infections

Tarceva approved in Switzerland for NSCLC

BMS discovers IGF-1R inhibitor with broad-spectrum in vivo antitumor activity

Treatment with CCR5 antagonist spares monkeys from collagen-induced arthritis

R-112 significantly improves symptoms of seasonal allergic rhinitis

New data on small and ultrasmall particles of iron oxide as contrast agents for MRI

Anti-TNF agent SD-06 in phase I trials

Potent and highly selective p38alpha MAPK inhibitor selected as a clinical candidate

Ixabepilone demonstrates activity in castrate metastatic prostate cancer

Experiments reveal activity of D-4F in asthma model

New treatments for psychotic disorders described in patent literature

AstraZeneca discloses JNK3 inhibitors

Antibacterial oxazolidinones described in a patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...